Dose Level -1

BIOLOGICAL3 trials

Sponsors

Jichi Medical University, Institute of Cancer Research, United Kingdom, Baylor College of Medicine

Conditions

High Grade Serous Ovarian CancerKidney CancerLymphomaMyelomaRelapsed or Refractory B-Cell Non-Hodgkin LymphomaSarcomaSolid Tumors

Phase 1

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Jichi Medical UniversityRelapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Start: 2014-05-31End: 2017-03-31Target: 18Updated: 2014-11-06

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

RecruitingNCT06976892

Institute of Cancer Research, United KingdomHigh Grade Serous Ovarian Cancer

Start: 2025-08-31End: 2029-12-31Target: 33Updated: 2025-08-13

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

Not yet recruitingNCT07297160

Baylor College of MedicineKidney Cancer, Lymphoma, Myeloma +2

Start: 2026-06-01End: 2044-12-01Target: 88Updated: 2026-03-04

Related Papers

Engineering of CD19-CAR T Cells from Non-Hodgkin Lymphoma Patients in a Closed System in Combination with Retronectin/OKT3 Stimulation

Blood2014-12-06